Keyphrases
ADHD Medication
15%
Adverse Events
15%
Airway Epithelial Cells
34%
Antiviral Treatment
23%
Attention Deficit Hyperactivity Disorder
58%
Bronchi
17%
Care Pathway
21%
Chronic Effects
34%
Clinical Efficacy
23%
Clinical Trials
17%
Cluster Randomized Trial
34%
Community Pharmacy
32%
Conductance
33%
Conventional Care
15%
Direct Observed Therapy
23%
Direct-acting Antivirals
14%
Drug Use
34%
Effect Study
23%
Epithelial Sodium Channel (ENaC)
16%
Forskolin
17%
H441
23%
HCO3
19%
HCV Treatment
23%
Hepatitis C
51%
Hepatitis C Treatment
44%
Hepatitis C Virus
77%
Hepatitis C Virus RNA
16%
Injecting Equipment
23%
Lung
15%
Methylphenidate
100%
Methylphenidate Treatment
26%
Na +
65%
Na+ Absorption
15%
Na+ Transport
18%
Opioid Substitution Treatment
27%
People Who Inject Drugs
58%
Pharmacy
34%
Point-of-care
17%
Prison
20%
Randomized Controlled Trial
35%
Scotland
44%
Serum and Glucocorticoid-regulated Kinase 1
23%
Stimulant Medication
15%
Sustained Virological Response
16%
SVR12
17%
Syrinx
16%
Tayside
23%
Treatment Regimen
23%
Wheezing
14%
Young children
23%
Medicine and Dentistry
5 (N,n Dimethyl)amiloride
8%
Adolescence
34%
Adverse Drug Reaction
11%
Antiviral Therapy
11%
Attention Deficit Disorder
34%
Barium Ion
11%
Base
11%
Bronchiolitis
8%
Bumetanide
5%
Bupivacaine
11%
Care Pathway
16%
Cohort Analysis
23%
Community Pharmacy
7%
Community-Acquired Pneumonia
11%
COVID-19
11%
Diagnosis
11%
Drug Therapy
15%
Drug Use
23%
Epithelial Cell
11%
Epithelial Sodium Channel
11%
Hepacivirus
11%
Hepatitis C
23%
Hepatitis C Virus
46%
Hospital Care
5%
Infection
5%
Lung
6%
Mannose Binding Lectin
11%
Messenger RNA
13%
Meta-Analysis
11%
Methylphenidate
34%
National Health Service
5%
Nurse
5%
Observational Study
11%
Odds Ratio
11%
Placebo
11%
Potassium Ion
11%
Reinfection
9%
Respiratory Disease
11%
Respiratory Tract Infection
14%
Secretion (Process)
11%
Sodium Ion
23%
Sulforaphane
5%
Systematic Review
11%
Toddlers
23%
Transcription Factor Nrf2
5%
Virus RNA
11%
Wheeze
15%
